BrightInsight Named Most Innovative Digital Health Platform Company by Global Brands Magazine

We are pleased to share that BrightInsight has been named the 2021 Most Innovative Digital Health Platform Company by Global Brands Magazine. We are honored to be among a group of prestigious organizations from around the world in the healthcare category including Cedars-Sinai Medical Center, Johns Hopkins Hospital and St. Jude Children’s Research Hospital. The complete list of this year’s winners in all categories, can be found here (and then click on “Healthcare”).

BrightInsight was selected for our commitment to innovation and quality, exceptional customer service, corporate growth and technology performance, as well as for our impactful marketing and thought leadership initiatives. As part of our mission to accelerate digital health innovation for our biopharma and medtech clients, BrightInsight is committed to sharing digital health insights through in-depth white papers, contributed articles, market research and interviews with the industry’s foremost thought leaders. From exploring the role of digital in accelerating immuno-oncology treatments, to understanding digital health regulatory changes such as the EU MDR, to assessing the impact of COVID-19 on digital adoption amongst the world’s top biopharma companies, to identifying strategies for Commercial and R&D biopharma execs to partner to accelerate innovation, BrightInsight has covered a myriad of topics.

From a growth standpoint, it has been another explosive year for our company—we secured $101M in Series C funding led by General Catalyst, and nearly tripled our valuation and headcount. We continue to accelerate time to market for leading biopharma and medtech companies, helping them to develop and launch digital health solutions in 12 months or less, including the recently announced disease management platform for AstraZeneca, AMAZE, that was launched at Mass General Brigham and featured at this year’s HIMSS conference.

This latest recognition reinforces our leadership in biopharma and medtech regulated digital health and is a tribute to our incredible team that is focused every day on our vision to improve patient outcomes globally through the power of digital. We look forward to continuing to share updates and industry insights with you all.

Back to Blog